Quick Answer
Protagonist Therapeutics, Inc reported Common Stock Shares Outstanding of 62.58 million shares for the year ending 2025.
- Protagonist Therapeutics, Inc showed an increase of +2.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Protagonist Therapeutics, Inc's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Protagonist Therapeutics, Inc's Common Stock Shares Outstanding has grown by 22,872.0%.
- Historical annual values: Fiscal year 2025: 62.58 million shares | Fiscal year 2024: 61.04 million shares | Fiscal year 2023: 57.71 million shares | Fiscal year 2022: 49.34 million shares | Fiscal year 2021: 47.84 million shares | Fiscal year 2020: 43.75 million shares | Fiscal year 2019: 27.22 million shares | Fiscal year 2018: 23.19 million shares | Fiscal year 2017: 21.09 million shares | Fiscal year 2016: 16.72 million shares | Fiscal year 2015: 272,409 shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: